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DEV5131SpMyb functions as an intramodular repressor to regulate spatial expression
of CyIIIa in sea urchin embryos
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*Present address: Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USAThe CyIIIa actin gene of Strongylocentrotus purpuratus is
transcribed exclusively in the embryonic aboral ectoderm,
under the control of 2.3 kb cis-regulatory domain that
contains a proximal module that controls expression in
early embryogenesis, and a middle module that controls
expression in later embryogenesis. Previous studies demon-
strated that the SpRunt-1 target site within the middle
module is required for the sharp increase in CyIIIa tran-
scription which accompanies differentiation of the aboral
ectoderm, and that a negative regulatory region near the
SpRunt-1 target site is required to prevent ectopic tran-
scription in the oral ectoderm and skeletogenic mes-
enchyme. This negative regulatory region contains a
consensus binding site for the myb family of transcription
factors. In vitro DNA-binding experiments reveal that a
protein in blastula-stage nuclei interacts specifically with
the myb target site. Gene transfer experiments utilizing
CyIIIa reporter constructs containing oligonucleotide sub-
stitutions indicate that this site is both necessary and suf-
ficient to prevent ectopic expression of CyIIIa. Synthetic
oligonucleotides containing the myb target site were used
to purify a protein from sea urchin embryo nuclear extracts
by affinity chromatography. This protein is immunopre-
cipitated by antibodies specific to the evolutionarily
conserved myb domain, and amino acid sequences obtained
from the purified protein were found to be identical to
sequences within the myb domain. Sequence information
was used to obtain cDNA clones of SpMyb, the S. purpura-
tus member of the myb family of transcription factors.
Through interactions within the middle module, SpMyb
functions to repress activation of CyIIIa in the oral
ectoderm and skeletogenic mesenchyme.
Key words: Strongylocentrotus purpuratus, myb, CyIIIa,
transcriptional regulation, embryogenesis
SUMMARYINTRODUCTION
The CyIIIa gene of Strongylocentrotus purpuratus encodes a
cytoskeletal actin that is specifically transcribed in the aboral
ectoderm of the embryo and larva, under the control of a 2.3
kb cis-regulatory domain. Studies of this cis-regulatory system
have served as a paradigm for the analysis of information pro-
cessing systems that regulate transcription during embryonic
development (see Kirchhamer et al., 1996, for review). In vitro
analyses have identified over twenty protein target sites within
the CyIIIa regulatory domain, at which specific interactions
with at least nine different transcription factors occur (Calzone
et al., 1988; Thézé et al., 1990). All of these factors have been
isolated by affinity chromatography (Calzone et al., 1991;
Coffman et al., 1992; Char et al., 1993; Zeller et al., 1995a;
Coffman et al., 1996), and eight of them have been cloned (see
Fig. 1A). Concomitantly, in vivo studies utilizing gene transfer
technology have identified regulatory functions for each target
site (Franks et al., 1990; Hough-Evans et al., 1990; Kirchhamer
and Davidson, 1996; Coffman et al., 1996).
The CyIIIa cis-regulatory domain consists of two function-
ally distinct modules, the locations of which are shown in Fig.
1A (Kirchhamer and Davidson, 1996; Kirchhamer et al., 1996).The proximal module includes both positively and negatively
acting spatial control elements which together suffice to initiate
expression exclusively in the aboral ectoderm early in embryo-
genesis. The middle module functions dominantly later in
embryogenesis. It is required both for the sharp increase in
CyIIIa transcription that occurs after blastula stage, and for
spatially localizing that transcription to the aboral ectoderm
(Kirchhamer and Davidson, 1996). It was recently demon-
strated that the positive regulatory function of the middle
module is mediated by the SpRunt-1 target site (Coffman et
al., 1996). Two negative spatial regulatory functions have also
been identified within the middle module. Interactions with the
zinc finger repressor SpZ12-1 (see Fig. 1A) are required to
prevent transcription in the skeletogenic mesenchyme (Wang
et al., 1995). A second middle module repressor was inferred
from in vivo competition (Hough-Evans et al., 1990), and from
the results of deletion of a region of the middle module known
as the P7II target site (Fig. 1A; Kirchhamer and Davidson,
1996). Interactions at this site were found to be required to
prevent ectopic transcription in both the oral ectoderm and
skeletogenic mesenchyme. The P7II target site had been
mapped to a 63 bp sequence within the middle module which
is shown in Fig. 1B. The purpose of the present investigation
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shown in Fig. 1B mediate its negative regulatory function, and
to identify the responsible repressor protein.
Previous analysis of the P7II region revealed that it contains
binding sites for SpGCF1 (Fig. 1A,B), a transcription factor
that binds multiple target sites in the regulatory domains of
various genes (Zeller et al., 1995a). The ability of SpGCF1 to
homomultimerize and loop DNA in vitro led to the hypothesis
that its function may be to facilitate direct communication
between proteins bound at distant target sites (Zeller et al.,
1995b). The facts that target sites for SpGCF1 are widespread,
occurring in both the proximal and the middle modules, and
that where analyzed, these target sites function positively in
transcriptional regulation (Franks et al., 1990; Kirchhamer et
al., 1996), suggested that SpGCF1 is not the factor responsi-
ble for the negative spatial function of the P7II region.
However, because of the high abundance of SpGCF1 in nuclear
extracts, it was initially difficult to detect any other proteins
that bind in the same region. To overcome this difficulty we
made use of automated sequential affinity chromatography
(Coffman et al., 1992) to analyze P7II-specific binding proteins
that remain in nuclear extract following passage over columns
bearing specific SpGCF1 sites. We thus discovered that a sea
urchin myb-domain transcription factor, SpMyb, specifically
binds the P7II target site. Gene transfer experiments demon-
strate that the ectopic expression mediated by the SpRunt-1
interaction within the middle module of the CyIIIa gene
(Coffman et al., 1996; Kirchhamer et al., 1996) is repressed by
the addition of a single synthetic Myb site. SpMyb is thus a
key negative spatial regulator of the middle module.
MATERIALS AND METHODS
Construction of reporter genes
Oligonucleotides
Synthetic oligonucleotides used in the constructs shown in Fig. 1C are
listed below. The following double-stranded oligonucleotides (corre-
sponding to the boxed sequence in Fig. 1B) were used both as probes
in DNA-binding assays and as artificial target sites in reporter con-
structs (Fig. 1C). Myb target sites are in larger boxes and in bold face,
GCF1 sites are in smaller boxes, nucleotide base substitutions that
alter the wild-type sequence are underlined, and sequences contain-
ing SacII sites for the purpose of cloning are in lower case.
Oligonucleotide pair MG:
Note that four of the five base substitutions in oligonucleotide pair
G fall outside of the canonical myb target site, within sequences that
in the wild-type are partial myb recognition sequences (4/6: TAAC),
and also that these changes introduce an additional GCF1 site. For the
purpose of cloning, the two individual oligonucleotides of each pair
were annealed, concatamerized using T4 DNA ligase, and digested
with SacII.
Constructs
The 9.4 kb CyIIIa.CAT construct (line 1 of Fig. 1C) described by
MG.s: 5′−ccgcggCTAACCGTTACCCTTAACCTAA−3′
MG.as: 3′-GATTGGCAATGGGAATTGGATTggcgcc-5′
Oligonucleotide pair G:
G.s: 5′-ccgcggGTACCCGGTACCCTTACCCTAC-3′
G.as: 3′-CATGGGCCATGGGAATGGGATGggcgcc-5′
Oligonucleotide pair M:
M.s: 5′-ccgcggTTAACCGTTAACCTTAACCTAA-3′
M.as: 3′-AATTGGCAATTGGAATTGGATTggcgcc-5′Kirchhamer and Davidson (1996) was used as control construct. Con-
structs MG.CAT, M.CAT and G.CAT (lines 3, 4 and 5 of Fig. 1C) were
generated by opening plasmid D P7II.CAT (line 2 of Fig. 1C; Kirch-
hamer and Davidson, 1996) at the unique SacII site and inserting the
oligonucleotide pairs MG, M or G, respectively (see above). The
resulting constructs were sequenced to verify that they contained only
a single oligonucleotide insert, and that the insert was in the proper
orientation with respect to the wild-type sequence.
All plasmids carry the remaining complement of regulatory sites of
the CyIIIa 5¢ regulatory region, transcription initiation site, 5¢ leader
sequence of the primary transcript and a CyIIIa-CAT fusion gene. The
plasmids were linearized for microinjection at unique SphI or KpnI sites.
Microinjections and whole-mount in situ hybridization
Gametes of Strongylocentrotus purpuratus were obtained, microin-
jections carried out and embryos cultured as described previously
(McMahon et al., 1985; Kirchhamer and Davidson, 1996). Embryos
were collected at the appropriate stage and processed for whole-mount
in situ hybridization (Ransick et al., 1993; Kirchhamer and Davidson,
1996). Embryos were analyzed and images stored with an imaging
system using ProgRes software and a Zeiss Axioskop microscope.
Large-scale embryo culture, protein purification, and
protein microsequencing
Large-scale embryo cultures, preparation of nuclear extracts, and
automated sequential affinity chromatography (ASAC) were carried
out as previously described (Calzone et al., 1991; Coffman et al.,
1992). For protein microsequencing, peak fractions from four separate
ASAC runs of an affinity column bearing oligonucleotide pair M (see
above) were pooled, dialyzed against Buffer 0.1 (20 mM Hepes-KOH,
pH 7.9; 0.1 M KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 0.1%
Nonidet P-40, 0.1 mM PMSF, 20% glycerol), brought to 20 ng/m l with
poly(dIdC/dIdC), and reloaded onto a tandem series of four columns
bearing the M oligonucleotide pair. The columns were loaded and
eluted using a Gilson ASPEC programmed with our standard ASAC
Software (Coffman et al., 1992), and the fractions analyzed by both
electrophoretic mobility shift and SDS-PAGE. This second round of
affinity purification in the presence of nonspecific competitor DNA
resulted in a substantial enrichment of the myb-specific DNA-binding
activity. Peak fractions were again pooled, dialyzed against Buffer 0.1
(without glycerol), and concentrated by ultrafiltration using Centricon
10 mini-concentrators (Amicon). The pooled, concentrated M
oligonucleotide column eluate was brought to 1% trifluoroacetic acid,
subjected to reverse phase HPLC (SMART, Pharmacia) on a C4
column (ABI), and eluted with a linear acetonitrile gradient. Individ-
ual peaks were collected and analyzed by electrophoretic mobility
shift and by SDS-PAGE. Myb-specific DNA-binding activity was
found in a single peak which contained two species of protein, an
abundant species of approx. 30 kDa and a minor species of approx.
80 kDa. The approx. 30 kDa species corresponds in size to the pre-
dominant myb-specific DNA binding protein identified by 2-dimen-
sional EMSA (J. A. Coffman, unpublished result), and probably rep-
resents a proteolytic fragment of the full-length protein (see Results).
This fraction was subjected to digestion with a lysylendopeptidase
(Achromobacter Protease 1; Wako). The resultant peptides were
resolved by reverse phase HPLC (Pharmacia SMART equipped with
a C18 column) and sequenced on a Porton automated sequencer.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) were performed essen-
tially as described by Calzone et al. (1988); Coffman et al. (1996).
For detection of myb DNA-binding activity in either affinity column
eluate or in vitro translation reactions, 20 ng/m l poly (dIdC/dIdC) was
used as nonspecific competitor in each 10 m l binding reaction, which
included 1 m l of protein extract. For detection of immunoprecipitated,
renatured myb DNA-binding activity, 10 ng/m l poly (dIdC/dIdC) was
used in each 15 m l binding reaction, which included 10 m l of renatured
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visualized using a phosphorimager and ImageQuant software
(Molecular Dynamics).
Immunoprecipitations
Immunoprecipitation of affinity-enriched myb DNA-binding activity
was performed as follows: 100 m l of P7II affinity column eluate was
brought to 1% SDS and heated to 90°C to denature the proteins, then
brought to 1 ml in immunoprecipitation buffer (60 mM Na2HPO4, 40
mM NaH2PO4, 1% sodium deoxycholate, 0.1% SDS, 2 mM EDTA,
150 mM NaCl, 1 mM PMSF). 250 m l aliquots of this preparation were
incubated overnight at 4°C with 25 m l protein A sepharose that had
been pre-coated with either anti-BP-2 antibodies (Boyle et al., 1986)
or antibodies from nonimmune serum from a different rabbit. The
resulting immunoprecipitates were collected by centrifugation,
washed three times in 1 ml each of PBS, and eluted with 100 m l denat-
uration buffer (20 mM Hepes-KOH, pH 7.9; 0.1 mM EDTA, 1 mM
dithiothreitol, 6 M guanidinium-HCl, 1 mM MgCl2). The eluted
proteins were renatured over 0.5 ml Biogel P6 (Biorad) columns that
had been pre-equilibrated in renaturation buffer (10 mM Hepes-KOH,
pH 7.9; 0.1 M KCl, 1 mM dithiothreitol, 0.1% Nonidet P-40, 10%
glycerol) and subjected to EMSA as described above.
cDNA cloning
A highly conserved region of the myb DNA binding domain was
amplified by polymerase chain reaction, using the degenerate primers
designed by Stober-Grässer et al. (1992). Plasmid prepared from a
blastula-stage l Zap cDNA library was used as template. The
amplified 168 bp fragment was excised, electroeluted, cloned into
pGEM-T (Promega), and sequenced. This fragment was then used to
screen a blastula-stage l Zap cDNA library by standard procedures. A
first round of screening yielded two clones, 7.1.1 and 15.1.1, which
contain inserts of approx. 1.2 and approx. 1.5 kb respectively. The
latter insert was sequenced and found to contain an uninterrupted open
reading frame. An approx. 500 bp XbaI-EcoRI fragment from the 3¢
end of the 15.1.1 insert was therefore used to rescreen the blastula-
stage l Zap cDNA library, yielding clones 9.1.1, 10.1.1, and 12.1.1.
Clone 10.1.1 contains the longest insert (approx. 2.2 kb) and was
sequenced. The SpMyb sequence presented here was compiled from
the combined double stranded sequences of clones 15.1.1 and 10.1.1.
DNA sequence analysis
DNA sequencing and sequence analysis was carried out as previously
described (Coffman et al., 1996), using an ABI 373A automated
sequencer and IBI Pustell sequence analysis software. Nested
deletions of clones 10.1.1 and 15.1.1 were constructed using a
Pharmacia kit.
In vitro transcription and translation
In vitro transcription and translation were performed using Ambion
T3 mMessage Machine and reticulocyte lysate kits, respectively. For
in vitro transcription, clone 15.1.1 was linearized with BsmI, which
cuts at nucleotide position 711 of the sequence depicted in Fig. 5 (126
bp downstream from the myb domain). In vitro translation reactions
were carried out using the manufacturers protocol, except that the
reactions were supplemented with 0.1 mM L-methionine. The use of
nonradioactive methionine allowed for unambiguous detection of the
translation products by EMSA (described above).
Genomic and RNA blot hybridizations
Genomic DNA and RNA blot hybridizations were carried out as
described previously (Coffman et al., 1996), using as probe either an
XbaI-EcoRI fragment of SpMyb corresponding to a C-terminal
portion of the coding sequence, or the cloned PCR fragment corre-
sponding to repeat 3 of the DNA-binding domain. Probes were labeled
with [32P]dCTP (NEN), using the Oligolabeling kit from Pharmacia.Washes were carried out in either 0.1· SSC, 1% SDS (high strin-
gency) or in 1· SSC, 0.2% SDS (lower stringency) at 65°C.
RESULTS
Characterization of protein target sites within the
P7II region using synthetic oligonucleotides 
Fig. 1B shows the 63 bp sequence, referred to here as the P7II
region, which was previously shown to be required for
negative spatial regulation of CyIIIa (Hough-Evans et al.,
1990; Kirchhamer and Davidson, 1996). Earlier studies
revealed that this segment of DNA interacts with one or more
proteins (Calzone et al., 1988; Thézé et al., 1990). Our initial
experiments were therefore designed to determine exactly
what target sites lie within the P7II region. When the entire
P7II region is used as a probe, the protein most commonly
detected in crude nuclear extract by electrophoretic mobility
shift assays (EMSA) is SpGCF1, a relatively abundant protein
that functions positively in regulating CyIIIa (Franks et al.,
1990; Zeller et al., 1995a; Kirchhamer and Davidson, 1996).
Because the P7II region clearly functions negatively in regu-
lating CyIIIa, we suspected that it might contain a target site
for another protein, which would be obscured by the high
abundance of SpGCF1 in nuclear extracts. We found pre-
viously that a tandem series of columns bearing oligonu-
cleotides containing a highly specific SpGCF1 target site (P8II
from Thézé et al., 1990) can be used to remove this protein
efficiently from nuclear extracts, allowing downstream purifi-
cation of rarer proteins in the same sequential affinity chro-
matography run (Coffman et al., 1992). Nuclear extract was
thus passed over two columns bearing a SpGCF1 target site,
and then over a column bearing an oligonucleotide fragment
of the P7II region (boxed sequence in Fig. 1B). In addition to
the GCF1 site (shown in blue in Fig. 1B), the P7II oligonu-
cleotide contains a sequence (shown in red Fig. 1B) that
matches perfectly the consensus binding site for the myb
family of DNA-binding proteins, viz PyAACG/TG (in reverse
orientation in Fig. 1B; see Lipsick, 1996; Graf, 1992; and
Luscher and Eisenman, 1990 for reviews).
In order to distinguish between SpGCF1 and putative myb
DNA-binding activities eluted from the P7II affinity column, we
constructed synthetic 22bp oligonucleotides that dissociated
these sites. Three different double-stranded oligonucleotides
were synthesized: (1) a fragment of the wild-type sequence with
both the myb and GCF1 sites (oligo MG) that served as a control;
(2) a mutated sequence that abolishes the myb site but adds an
additional GCF1 site (oligo G); and (3) a mutated sequence that
abolishes the GCF1 site but retains the myb site (oligo M; see
Materials and Methods for oligonucleotide sequences). Each of
these oligonucleotides was used as a probe in EMSA experiments
in order to analyze the DNA-binding specificity of proteins eluted
from the P7II affinity column. As is shown in Fig. 2, both
oligonucleotides containing the myb target site (i.e., oligonu-
cleotides MG and M) specifically bound a protein eluted from
the wild-type P7II affinity column (Fig. 2A). In contrast, when
the same oligonucleotides were used in EMSA to probe total
nuclear extract, only SpGCF1 was detected, by probes G and MG
(Fig. 2B). Probe M detected nothing under these conditions in
total nuclear extract from blastula-stage embryos, indicating that
the active myb-site-specific factor is relatively rare in these
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Interactions at the myb target site function
negatively to regulate spatial expression of CyIIIa
Gene transfer experiments were performed to determine the
function of each of the target sites contained within the P7II
region. Toward this end, each of the synthetic oligonucleotides
used for the DNA/protein binding experiments described above
was separately cloned into
the deleted region of the
D P7II.CAT construct (Fig.
1C, lines 3-5). The resulting
constructs were microin-
jected into eggs, which were
then allowed to develop to
gastrula stage and analyzed
by whole-mount in situ
hybridization (WMISH). The
results of this experiment are
summarized quantitatively in
Table 1, and representative
examples are shown in Fig. 3.
Remarkably, each of the con-
structs that contained a ‘wild-
type’ myb site, i.e., MG.CAT
and M.CAT gave rise to
spatially normal patterns of
expression (Fig. 3A,B). This
result is quantitated in lines 3
and 5 of Table 1. Note that
the small fractions of
embryos displaying ectopic
expression of these con-
structs are comparable to the
fractions obtained with the
wild-type CyIIIa.CAT
construct (Table 1, line 1; see
also Kirchhamer and
Davidson, 1996). In contrast,
G.CAT, the construct con-
taining the mutated myb
target site, gave rise to sig-
nificant ectopic expression in
both the oral ectoderm and
the skeletogenic mes-
enchyme, as illustrated in
Fig. 3C1, C2. This result is
shown in line 4 of Table 1. It
is important to note that the
amount of ectopic expression
obtained with this construct
is similar to that observed
when D P7II.CAT is injected
(Table 1, line 2; Kirchhamer
and Davidson, 1996). Since
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is drawn to scale (as in A), but not thG.CAT includes a perfectly good GCF1 site, we conclude that
the latter site plays no role in the negative regulatory function
of the P7II region. In contrast, M.CAT, the construct lacking
GCF1 sites in the oligonucleotide insert, exhibited somewhat
lower levels of expression (Table 1, line 3), a result that is con-
sistent with the earlier evidence cited above that SpGCF1 facil-
itates transcriptional activation. These results demonstrate that,
within the context of the rest of the CyIIIa regulatory system,
the myb target site contained within the P7II region is
necessary and sufficient to prevent ectopic transcription in the
oral ectoderm and skeletogenic mesenchyme. Furthermore, the
five point mutations that eliminate interactions with the myb
site binding protein in vitro produce quantitatively the same
effect on spatial expression in vivo as does the entire 63 bp
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Fig. 2. Specific protein-DNA complexes formed with double
stranded oligonucleotides used in this study. Each of the
oligonucleotides (described in Materials and Methods) was used both
as labeled probe and unlabeled competitor in EMSA with either (A)
nuclear proteins eluted from an affinity column bearing a P7II target
site oligonucleotide, or (B) crude nuclear extract. Probes and
competitors used in each reaction are shown above each panel. M
designates an oligonucleotide containing only the myb-target site;
MG designates an oligonucleotide containing both myb and GCF1
target sites; and G designates an oligonucleotide containing only
GCF1 target sites. In reactions that included unlabeled
oligonucleotides as competitor, approximately 1,000-fold molar
excess was used with respect to the probe DNA. (A) Affinity-
enriched P7II-binding protein interacts with oligonucleotides M and
MG, but not with the oligonucleotide G. (B) SpGCF1 in crude
nuclear extract interacts with oligonucleotides G and MG, but not
with oligonucleotide M. The higher degree of binding to probe G
reflects that this oligonucleotide contains two core GCF1 sites (see
Materials and Methods).
Fig. 3. Spatial expression patterns of reporter constructs. The spatial
distribution of CAT transcripts was detected by WMISH, using a
digoxigenin-labeled antisense CAT RNA probe. Expression domains
were analyzed in late gastrula-stage embryos (50-54 hours old),
shown with the oral ectoderm oriented to the right. (A) Embryo
expressing the MG.CAT fusion gene (line 3 of Fig. 1B) exclusively in
the aboral ectoderm territory. (B) Gastrula displaying M.CAT (line 4
of Fig. 1B) expression exclusively in the aboral ectoderm.
(C1) Gastrula showing ectopic expression of G.CAT in the oral
ectoderm (line 5 of Fig. 1B). (C2) Another embryo expressing
G.CAT in both oral and aboral ectoderm territories and in
skeletogenic mesenchyme cells (black arrowheads). P7II deletion studied earlier by Kirchhamer and Davidson
(1996).
Isolation of a cDNA clone encoding SpMyb, a sea
urchin transcription factor that contains a myb DNA
binding domain
To determine whether the affinity purified myb-binding proteinin fact contains a myb related DNA-binding domain, we first
made use of a polyclonal antibody (anti-BP-2) generated
against the vertebrate myb DNA-binding domain (Boyle et al.,
1986). Anti-BP-2 has been shown to immunoprecipitate myb-
related proteins from a wide variety of metazoan species. The
EMSA depicted in Fig. 4 shows that the protein eluted from
the P7II affinity column is indeed immunoprecipitated with
anti-BP-2, but not with non-immune antibodies.
Affinity purified myb-binding proteins were further purified
to near homogeneity by reverse-phase HPLC (data not shown),
and subjected to amino acid sequence analysis. Two amino acid
sequences were recovered that fall within the highly conserved
first and third repeats of the myb DNA-binding domain (see
Fig. 5, highlighted sequence). This result directly demonstrates
the existence in the nuclei of sea urchin embryos of a myb
domain protein that can be purified by virtue of interaction with
its CyIIIa target site.
To obtain cDNA clones encoding this protein, degenerate
primers (Stober-Grässer et al., 1992) were used in a polymerase
chain reaction to amplify a blastula-stage cDNA specifying a
highly conserved fragment of the myb DNA-binding domain.
The amplified fragment was cloned, sequenced, and used as a
probe to screen a blastula-stage cDNA library. With this probe
we isolated clones for SpMyb (see Materials and Methods), the
combined sequences of which are shown in Fig. 5. Note that
the open reading frame begins at the 5¢ end of the sequence.
The first methionine residue, which aligns approximately with
the N-termini of vertebrate myb proteins (see Fig. 6), occurs at
amino acid position 4 in the open reading frame. However, we
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Table 1. Late gastrula-stage expression of constructs containing either a wild-type or mutated Myb target site*
% Oral % Skeletogenic
Total Labeled:not labeled % Aboral ectoderm ectoderm mesenchyme
Construct scored (interpretable)† % expr‡ expression§ expression§ expression§
CyIIIa.CAT 188 121:67 (113) 64.4 93.8 7.0 5.4
D P7II.CAT 328 206:122 (165) 62.8 95.2 17.6 36.4
MG.CAT 239 136:103 (122) 56.9 96.7 4.9 7.4
G.CAT 241 168:73 (145) 69.7 97.2 15.2 20.0
M.CAT 213 96:117 (91) 45.1 95.6 3.3 6.6
*Gastrulae were collected at 48-54 hours postfertilization; for constructs see Fig. 1C.
†Embryos with more than two labeled cells were scored as labeled.
‡% expression is [S labeled embryos/S labeled and unlabeled embryos]· 100.
§% aboral ectoderm, oral ectoderm, or skeletogenic mesenchyme expression is [S embryos labeled in particular territory/S labeled, interpretable
embryos]· 100.cannot be certain that this methionine represents the actual N
terminus of SpMyb. The open reading frame depicted in Fig. 5
encodes an approximately 77 kDa protein, which is in the size
range of known myb proteins (Boyle et al., 1986). The size also
corresponds to the minor approx. 80 kDa species found in the
purified preparation of SpMyb from which the amino acid
sequence was obtained (see Materials and Methods).
Fig. 6 depicts an alignment of SpMyb with various other
members of the myb family from vertebrates and
Drosophila. Consistent with their common deuterostome
relationship, the highest degree of similarity occurs between
SpMyb and vertebrate A-Myb (39% identity), while slightly
less correspondence occurs between SpMyb and vertebrate
B-Myb (36% identity), and c-Myb (33% identity). The simi-Fig. 4. The Myb-site oligonucleotide (M) binds a myb-related DNA-
binding protein. The anti-BP-2 polyclonal antibody, generated
against the conserved myb DNA-binding domain (Boyle et al.,
1986), was used to immunoprecipitate proteins eluted from the M
oligonucleotide affinity column as described in the Materials and
Methods. Nonimmune serum was used as a control. Renatured
proteins recovered from each immunoprecipitate were subjected to
EMSA. The lane labeled NI depicts an EMSA performed using
proteins recovered from beads coated with antibodies from
nonimmune serum; the lane labeled BP-2 depicts an EMSA
performed using proteins recovered from beads coated with anti-BP-
2 antibodies.larity between SpMyb and the Drosophila Myb is lowest
(31% identity); moreover, DmMyb contains a long stretch of
amino acids at the N terminus that are not found in any of
the other aligned sequences, and is lacking certain regions
that are found in both SpMyb and in all the vertebrate homo-
logues. As can be seen in Fig. 6, the myb DNA-binding
domain is the highest region of conservation, containing the
three tandem repeats that form the multiple helix-turn-helix
motifs of this domain. More C-terminal regions are also
conserved. Some of these contain potential sites of phos-
phorylation by proline-directed serine/threonine kinases,
including S528 of murine c-Myb (S533 in chicken c-Myb).
This site (boxed in Fig. 5) is S549 of SpMyb. Phosphoryla-
tion of this serine has been shown to contribute to negative
functions of vertebrate c-Myb, possibly by modulating
specific protein-protein interactions (Aziz et al., 1995;
Miglarese et al., 1996).
In order to demonstrate that the cloned SpMyb is able to
bind specifically to the myb target site from the CyIIIa regu-
latory domain, a fragment of SpMyb corresponding to the
DNA-binding domain was transcribed and translated in vitro,
and subjected to EMSA with the M oligonucleotide as probe.
As can be seen in Fig. 7, the SpMyb protein fragment specif-
ically interacts with the functional myb target site (oligonu-
cleotide M), but not with the mutated target site (oligonu-
cleotide G).
SpMyb is encoded by a single-copy gene which
gives rise to a single embryonic transcript
The results illustrated in Fig. 8 indicate that SpMyb is the only
myb-family member in sea urchin embryos. Fig. 8A shows a
genome blot of EcoRI-digested DNA from three different indi-
viduals that was hybridized with a fragment encoding the C-
terminal region of SpMyb. The single bands in lanes 1 and 2
indicate that these individuals are each homozygous for two
different restriction fragment variants. The two bands in lane
3 indicate that this individual is either homozygous for a third
variant containing an internal EcoRI site, or is heterozygous,
carrying two different alleles. The degree of polymorphism
apparent on this blot is consistent with that found in natural
populations (Britten et al., 1978). When the genome blot was
stripped and rehybridized at lower stringency with a probe rep-
resenting the myb DNA-binding domain, essentially the same
result was obtained (data not shown), suggesting that there is
only one canonical myb-domain protein encoded in the
genome of S. purpuratus.
4723SpMyb functions as a spatial repressorTo determine the size of the SpMyb transcript, poly(A)+
RNA isolated from blastula-stage embryos was transferred to
nylon and hybridized with the same fragment as used to probe
the genome blot. The results are illustrated in Fig. 8B, whichAGAAAATTGATGGGTGATTACGACGACACAGACAG
(R  K  L) M  G  D  Y  D  D  T  D  S
TCATCATTCTATTCCAGGAAAGAGATCAGCCGAGC
 S  S  F  Y  S  R  K  E  I  S  R  A
                               r1
ACGCTAGACTGGAAACTTATCGGTAGCTTCTTCCC
 T  L  D  W  K  L  I  G  S  F  F  P
CTGGTCAAAGGTCCCTGGACTACAGAGGAGGATGA
 L  V  K  G  P  W  T  T  E  E  D  E
       r2
AAGTTTCTGGTGGGGCGCACAGGCAAGCAGTGCAG
 K  F  L  V  G  R  T  G  K  Q  C  R
                                   
GAGGAGGATTACATCATCTATGAAGCTCATAAGAA
 E  E  D  Y  I  I  Y  E  A  H  K  K
GCTATCAAGAACCACTGGAACTCCACTATGAAGAG
  A  I  K   N  H  W  N  S  T  M  K  R
TATACACACACTAATGATAACCAGAAACCATGTAG
 Y  T  H  T  N  D  N  Q  K  P  C  S
AGAGATGCTCTGAGGATGAGAGGTCAGGGCCAGCG
 R  D  A  L  R  M  R  G  Q  G  Q  R
GAAGGTTCAAAGGTCAAACCAGGGGTCAAGACTCC
 E  G  S  K  V  K  P  G  V  K  T  P
CATGATCTGATTGAGACCAGCGGTCATCCCTTTGA
 H  D  L  I  E  T  S  G  H  P  F  D
ACTCCCATTAAGTTCACCCATATGAACACCAAAGG
 T  P  I  K  F  T  H  M  N  T  K  G
TCAGGTGGTCTCATTCCCATCACATCACCCGTCAC
 S  G  G  L  I  P  I  T  S  P  V  T
AGAACAAGCTCCGCCTCCTTTGATGTTTCCATGGA
 R  T  S  S  A  S  F  D  V  S  M  D
CAGGGTACACCCATTAAGACCCTCCCCTTCTCACC
 Q  G  T  P  I  K  T  L  P  F  S  P
ACCTCCACTCCGATTGGTGGAAACCATTCACAAGC
 T  S  T  P  I  G  G  N  H  S  Q  A
                                   
CGCTCGTTGATTGACACACCCAGGACACCTACACC
 R  S  L  I  D  T  P  R  T  P  T  P
                *        *
CCGCACACCCCGAACCAGCTTTCTGATATCTCAGA
 P  H  T  P  N  Q  L  S  D  I  S  E
       *
AAACGTGCCATCCTGCAGAAGGCCGAATCAATATC
 K  R  A  I  L  Q  K  A  E  S  I  S
                                  *
AATTTGACTGGAGACGAGACTAGACAAGAAGAAGC
 N  L  T  G  D  E  T  R  Q  E  E  A
GGTCAAGGGTCAATCCTCGGTGGTGAAATGAGTAT
 G  Q  G  S  I  L  G  G  E  M  S  M
ACAAGGCCAAAGGTCAAAGTTGAGCCAGCCAACGG
 T  R  P  K  V  K  V  E  P  A  N  G
CTGGGACAGACGAGAGACCAGCAGTTCATGAGCGG
 L  G  Q  T  R  D  Q  Q  F  M  S  G
GGTCAAAGGTCATATAGTATATCTGTTTCTTGTCA
TACCCATGACCGAGATTCCAGGCCTGTATTTATTA
AGATTCTAACATGATATCACTCAACTGATAAGCCC
CATGATTGTAATAATTTTCCGCTTATATAGCGCTT
TGGAAACATATGCGATCCTACAATACTCATTGATC
TATGTTGTATAGCTCCCTCTCAAGGTCAAGATATT
TTTGAAAATTATATATCACAACTACATATTCTGAG
AAAATTTACCGGGAGCACCGGTAAATTTTTATATT
TACACCCACAGGGGCATCCAAATATATAAAAATTG
TAATACAATGTCTCTAAGCGCTTTTACAGATATAC
CCACTCTCTGGGGAGCATTCCAGCCAGGCGTTAAT
GGATATTAGTGCCGTGTTGGGATTCGAATCCTCGA
GCTTCCACGACACTCCCATAATACGATTCACGTTT
Fig. 5. The cDNA sequence
and conceptual translation
of SpMyb (GenBank
accession no. U96090).
While the open reading
frame begins at the 5¢ end
of the sequence, a
methionine that
approximately aligns with
the N-termini of vertebrate
myb proteins (see Fig. 6) is
found at position 4 (in
boldface; this is position 1
in the numeration of the
amino acid sequence). It is
not known whether this is
the actual start codon of
SpMyb; the parentheses
around the first three amino
acid residues of the ORF
indicate that they may or
may not be translated. The
myb DNA-binding domain
is underlined, with the
beginning of each of its
three imperfect tandem
amino acid repeats (r1, r2,
r3) indicated by arrows.
Amino acid sequences
obtained from purified
protein are highlighted.
Asterisks in bold-face
underneath amino acids
mark potential
phosphorylation sites; the
boxed Serine (S) represents
a potentially
phosphorylated residue
with known regulatory
function in vertebrate c-
Myb (Aziz et al., 1995;
Miglarese et al., 1996). The
termination codon is also
marked by an asterisk.shows that SpMyb is encoded by a single transcript at this
stage, of approximately 6 kb. No additional transcripts were
detected when the conserved region of the myb domain was
used to probe this same blot (data not shown). We thereforeTGCTAGCGATGGAGACGATTACACGGATCAGGATATGAGTGATTCGTCCCATGGA   90
  A  S  D  G  D  D  Y  T  D  Q  D  M  S  D  S  S  H  G    27
AAGATGGACAAAGGATGAGGACGACATGCTGAGGCAAGCCATTGAAGTCCATGGC  180
  R  W  T  K  D  E  D  D  M  L  R  Q  A  I  E  V  H  G    57
AAACCGATCTGAGCTCCAATGTTTCCATCGCTGGCAGAAGGTCCTGAACCCTGAC  270
  N  R  S  E  L  Q  C  F  H  R  W  Q  K   V  L  N  P   D    87
GAGAGTGGTTGAGTTGGTTCGTGAGCATGGCCCTAAGCGTTGGTCTCTCATCAGC  360
  R  V  V  E  L  V  R  E  H  G  P  K  R  W  S  L  I  S   117
GGAGAGATGGCATAATCATCTGAATCCTGATATAAAGAAGTCTGCTTGGACTAAA  450
  E  R  W  H  N  H  L  N  P  D  I  K  K  S  A  W  T  K   147
                                      r3
ACTTGGTAACAGATGGGCTGAGATAGCAAAGCTTCTTCCAGGAAGGACGGACAAT  540
  L  G  N  R  W  A  E  I  A  K   L  L  P  G  R  T  D  N    177
GAAAGTAGAGACATGTAACCCCTACACCCCCAGCAAGACAACCAAGACACCTCAC  630
  K  V  E  T  C  N  P  Y  T  P  S  K  T  T  K  T  P  H   207
CAGTAGCTCAAAGATATACACTCCAGATAGCGACTTCATGAATGCTAATTCCATA  720
  S  S  S  K  I  Y  T  P  D  S  D  F  M  N  A  N  S  I   237
TGTGGTGCGTACCCTCTACCCGATGGGTCACGACACCCTAGGTCAAGATGAAGGG  810
  V  V  R  T  L  Y  P  M  G  H  D  T  L  G  Q  D  E  G   267
GCAGAAATGGCTGATCATGGACAATTGTGGTGAAATCTCACCTTTCAGAGATTTC  900
  Q  K  W  L  I  M  D  N  C  G  E  I  S  P  F  R  D  F   297
TGACAAGGACAATGGAATATCAACCTTTGACCTTTCACTGGGGGTCAATTCCAGT  990
  D  K  D  N  G  I  S  T  F  D  L  S  L  G  V  N  S  S   327
ATCTATTGACTATCGTTTTGATGGCCAGGCGCTTCTAGACCTGTCACGTGAGGCC 1080
  S  I  D  Y  R  F  D  G  Q  A  L  L  D  L  S  R  E  A   357
ATCCAAGTTCAGCACCCCTCCTACCATCCTCAGAAAGGCCAAGCGCAAGCGAGTT 1170
  S  K  F  S  T  P  P  T  I  L  R  K  A  K  R  K  R  V   387
TACATCATTAAGCTCCACCCTGAACACACCTAACACATCCCGGTACAAGACGCCT 1260
  T  S  L  S  S  T  L  N  T  P  N  T  S  R  Y  K  T  P   417
CTCACAGTTTTTGAATGGAAGCACCTCGGCAACATGCTCCTCCTCTTTACTGCTC 1350
  S  Q  F  L  N  G  S  T  S  A  T  C  S  S  S  L  L  L   447
CACTCCCTCAATGCTCACAACACCAGCTGGCATGTTCCGCACCCCTCGGATCCGA 1440
  T  P  S  M  L  T  T  P  A  G  M  F  R  T  P  R  I  R   477
                                         *
CTTCAAGGATGCCCTCGCAGCCATAGAGAAGGCAGGAGGACCAATCAGGAAAATG 1530
  F  K  D  A  L  A  A  I  E  K  A  G  G  P  I  R  K  M   507
GATCATTGCTCGAGACGAGAGAGAGGGGCTCAACAAGATCGCGATTAACCAATTA 1620
  I  I  A  R  D  E  R  E  G  L  N  K  I  A  I  N  Q  L   537
ACCTGTGAAGAAAGTAAGGAAGTCGCTGTCCAGCTGCATGCAGAGAGAAAAGGAA 1710
  P  V  K  K  V  R  K  S  L  S  S  C  M  Q  R  E  K  E   567
TGATGAGAGCATCCTTGCATCAAGTCTGCTGATGTCGCCCCCTGTAGGCAGTAAA 1800
  D  E  S  I  L  A  S  S  L  L  M  S  P  P  V  G  S  K   597
GAAAGCTCTTAACGAAGCTTTCAACATGCCTTCGACCCCGTCCCCTGTCGCCCCC 1890
  K  A  L  N  E  A  F  N  M  P  S  T  P  S  P  V  A  P   627
ACCTGTATTTCAACAAACCAAGGGATCTCGAGACAAGGAATGGTGGCAGATCACA 1980
  P  V  F  Q  Q  T  K  G  S  R  D  K  E  W  W  Q  I  T   657
TCAAGCGCGACGGATGATTCTACGAGATCGTGTTCCGAGGTCGCTCGTCCTCTAA 2070
  Q  A  R  R  M  I  L  R  D  R  V  P  R  S  L  V  L  *   686
TGTCTGTCAACATTAAAGCTAGGAATGTAGTTTGAACCCGTAGTAGATTGTTTCA 2160
ATTCAAAGATTAATGCATGCTCAGTGAGTACTTCATTTAACTGATCGAATTACGT 2250
TGTTCAGATAGGTTTCGGTAATCCAGCGCATTTTTATCCATTATGACGTCTGTGT 2340
AAAGGTAATACAAAGTTTTGGTATGGGGTCATGTATCCGGTTCAAATGAACATAT 2430
GTTGTCGCGGTTGAAATCGAGTCTAAAATTATGAAATTGTAGATAATAAACTCTT 2520
AATTAAGCTATAAAACAATGTTTCTTGACCGAAATCGACCGATTAGCTATTCCCG 2610
AATTTCATGGTCGCAGCTACCATCGTACGGCCGTAGGCGCCATTTGAAATTTATC 2700
CAATTTTACTCGAAAACAAAAGTGTTTCAGGGGCTAAATTTTCTAGTGCTTATAA 2790
TAAAGAATCATTGTCCACCCAATTTTCAAAATTTCCCAAAACTTTGTATTACCTT 2880
TATTACCCTGATCATTGGATTTGATGCTTGCCCGCACACACTGTGTGCACAATCT 2970
TGACCATTTAACATCTGGGTGGAGAGTAGCAAGTGCAGGTTAATATCTTGCTGAA 3060
CCTTCGCATCTCCAGGCAAGCGCCTTAAATCACTCGGCCACGACGCTCCCACGAC 3150
CTGTATCTTATAACACAG                                      3203
4724 J. A. Coffman and othersconclude that, within the limits of detection employed here,
SpMyb encodes the only myb-domain protein expressed in
blastula-stage embryos of S. purpuratus.
Distribution of SpMyb transcripts in prism-stage
embryos
Whole mount in situ hybridization was employed to visualize
the distribution of SpMyb transcripts in prism-stage embryos.
Examples of the staining pattern obtained with an antisense,
digoxigenin-labeled SpMyb probe are shown in Fig. 9B,D. As
a control, embryos were stained with Endo16, which is specif-
ically localized to the midgut and hindgut at this stage (Fig.
9A,C; Ransick et al., 1993). In contrast, SpMyb transcripts
appear to be largely localized to the oral ectoderm, mes-
enchyme and endoderm at this stage (Fig. 9B,D). SpMyb is
therefore present in regions where it is required to repress
CyIIIa transcription (oral ectoderm and mesenchyme), and in
other regions as well (endoderm). The temporal expression
pattern, as well as a more detailed analysis of the spatial patternFig. 6. Multiple sequence alignment of SpMyb with three vertebrate myb
myb protein from Drosophila melanogaster (DmMyb). The alignment w
SpMyb, the first methionine residue in the sequence shown in Fig. 5 was
positions that are found in common between SpMyb and at least one of t
sites of phosphorylation previously defined in the murine homologue of of both SpMyb transcripts and protein will be the subject of a
separate report.
DISCUSSION
SpMyb, a myb-domain transcription factor in sea
urchin embryos
We report here the cloning and initial characterization of
SpMyb, a sea urchin member of the myb family of transcrip-
tion factors. SpMyb was identified as a nuclear protein in sea
urchin embryos that specifically interacts with a functional
target site in the cis-regulatory domain of CyIIIa. This target
site, which lies within the region referred to as P7II in earlier
work (Hough-Evans et al., 1990; Kirchhamer and Davidson,
1996), is required to prevent ectopic expression of CyIIIa in
the oral ectoderm and skeletogenic mesenchyme. Six lines of
evidence indicate that SpMyb is the protein that mediates the
negative regulatory function of this target site in vivo: (i) when proteins (A-Myb, B-Myb, and c-Myb; each from Gallus gallus) and a
as performed using the Clustal V program (Higgins et al., 1992). For
 used as the N terminus in this alignment. Highlighted residues indicate
he other proteins. The diamonds above the aligned sequences indicate
c-Myb (Aziz et al., 1995; Miglarese et al., 1996).
4725SpMyb functions as a spatial repressor
Fig. 7. DNA-binding activity of SpMyb translated in vitro from RNA
encoded by the SpMyb cDNA clone. A fragment of the SpMyb cDNA
corresponding to the DNA-binding domain (nucleotides 1-720 in Fig.
5) was transcribed and translated in vitro, and subjected to EMSA with
the myb-site probe (oligonucleotide M). Lane 1, unprogrammed
reticulocyte lysate; note that there are proteins in the lysate that bind
the myb-site probe. Lanes 2-4, reticulocyte lysate programmed with
the SpMyb DNA-binding domain. In lane 3, 1,000-fold molar excess
of unlabeled oligonucleotide M was included as competitor; in lane 4,
1,000-fold molar excess of unlabeled oligonucleotide G was included
as competitor. Note that the reticulocyte myb binding proteins are also
competed by the M oligonucleotide. Use of the smaller myb DNA
binding domain as template for in vitro translation allowed the
reticulocyte and the sea urchin proteins (indicated by arrow) to be
distinguished by complex size.
Fig. 8. Genomic and RNA blots probed with SpMyb. (A) Blot of
EcoRI-digested genomic DNA from three different individuals,
hybridized with SpMyb at high stringency. The pattern of bands
shows that SpMyb is a single copy gene (see text). (B) Blot of
poly(A)+ RNA from 24 hour blastulae, hybridized with SpMyb at
high stringency. A single band of approximately 6 kb is detected.
Fig. 9. Visualization of SpMyb transcripts in prism-stage embryos by
WMISH. (A) Lateral view of a control embryo, hybridized with
Endo16, which is at this stage localized to the mid- and hindgut
(Ransick et al., 1993). (B1) Lateral view of an embryo hybridized
with SpMyb. (B2) Same embryo as in B1, focusing on the surface of
the ectoderm. (C) Anal view of a control embryo hybridized with
Endo16, as in A. (D1) Anal view of an embryo hybridized with
SpMyb. (D2) Same embryo as in D1, from a different focal plane.
Note that SpMyb transcripts appear to be more sparse or possibly
absent in the aboral ectoderm.cloned into the region of CyIIIa.CAT constructs from which
the P7II region had been deleted, short oligonucleotides
bearing the CyIIIa myb target site reconstitute the spatial
regulatory function of that region in vivo, whereas oligonu-
cleotides containing point mutations that alter bases known to
be critical for myb target-site recognition do not (Table 1 and
Fig. 3); (ii) a protein isolated from blastula-stage nuclear
extracts interacts specifically with oligonucleotides containing
the myb target site, as is shown by in vitro competition exper-
iments (Fig. 2); (iii) this protein is immunoprecipitated by an
antibody specific to the myb domain (Fig. 4); (iv) amino acid
sequences obtained from the affinity-purified protein are
identical to sequences in the conserved DNA binding domain
of SpMyb; (v) DNA and RNA blot hybridization experiments
employing different parts of cloned SpMyb as probe indicate
that there is only one canonical myb domain protein encoded
in the sea urchin genome, and that only a single species of
SpMyb transcript is expressed in the blastula-stage embryo
(Fig. 8); and (vi) SpMyb is expressed in the territories where
the P7II target site is required to prevent ectopic expression of
CyIIIa (Fig. 9). While it remains formally possible that a
protein other than SpMyb is actually responsible for the
negative spatial regulatory function of the P7II target site, thisalternative is now improbable, since no other proteins were
found to interact specifically with the P7II region, either by
EMSA or by the highly sensitive technique of affinity chro-
matography combined with EMSA.
Several regions of the sequence in SpMyb are also conserved
in various other myb proteins. As expected, the highest con-
servation occurs within the myb DNA-binding domain, the
primary structure of which is highly conserved in organisms as
distant as Dictyostelium discoideum (Stober-Grässer et al.,
1992; Lipsick, 1996). A C-terminal region previously shown
to be conserved in both Drosophila and vertebrate myb
proteins (reviewed by Lipsick, 1996) is also found in SpMyb.
In addition, SpMyb contains blocks of residues that are also
found in the ‘negative regulatory domain’ of vertebrate c-Myb
(Dubendorff et al., 1992). In vertebrates, c-Myb serves as an
4726 J. A. Coffman and othersactivator of some genes and as a repressor for others (see, e.g.
Reddy et al., 1994; Vandenbark et al., 1996; reviewed by
Lipsick, 1996). Vertebrate A-Myb has been shown to be an
activator where analyzed (see, e.g. Golay et al., 1994;
Takahashi et al., 1995). B-Myb has been shown to function
both as a repressor (Foos et al., 1992), and as a cell-type-
specific activator (Tashiro et al., 1995). We have shown that in
the sea urchin embryo, SpMyb functions as a repressor of
CyIIIa transcription. In the following we discuss evidence that
the specific target of that repression is the SpRunt-1 activator.
SpMyb functions as an intramodular repressor to
regulate spatial expression of CyIIIa
Previous analyses demonstrated that the middle module of the
CyIIIa regulatory domain becomes the dominant regulatory
module during differentiation of the aboral ectoderm after the
blastula stage of embryonic development, and that the activa-
tion function of the middle module is mediated by the SpRunt-
1 target site (Kirchhamer and Davidson, 1996; Coffman et al.,
1996). In addition, it was shown that constructs lacking the
entire middle module and retaining only the proximal module
produce normal patterns of expression even though they lack
the P7II regions, whereas constructs lacking the P7II region of
the middle module but in which the remainder of the middle
module is present are expressed ectopically (Kirchhamer and
Davidson, 1996). These results suggested that the P7II region
mediates repression by interfering with the transactivation
function of SpRunt-1 in the oral ectoderm and skeletogenic
mesenchyme. Such regulation could either be direct, by means
of protein-protein interactions between SpMyb and SpRunt-1,
or indirect, occurring by means of interactions of SpRunt-1 and
SpMyb with a common intermediate protein or proteins.
Intramodular or local repression, referred to as ‘quenching’ by
Gray and Levine (1996), endows the developmental cis-regu-
latory module with the independent capability of processing
spatial regulatory information in given regions or cell types of
the embryo (for discussion, see Arnone and Davidson, 1997;
Kirchhamer et al., 1996; Gray and Levine, 1996).
It is likely that SpRunt-1 is active not only in the aboral
ectoderm, wherein it functions to activate CyIIIa, but also in
the oral ectoderm and skeletogenic mesenchyme, where
SpMyb appears to be required to quench SpRunt-1-mediated
activation. Late in development SpMyb is itself expressed
strongly in the oral ectoderm, mesenchyme and endoderm. The
repressive functions of the middle module are evident only
after gastrulation at least in mesenchyme cells (Wang et al.,
1995; Kirchhamer et al., 1996), and the localized expression
of SpMyb occurs at this time. Thus its function as a repressor
appears to be transcriptionally regulated in the postgastrular
embryo, the terminal period of differentiation for many
embryonic cell types.
The CyIIIa middle module encodes information that
promotes evolutionarily conserved interactions
between transcriptional regulatory proteins
The putative functional interaction between SpMyb and
SpRunt-1 is interesting in light of the known interactions
between vertebrate homologues of these two transcription
factors. Vertebrate myb-domain and runt-domain factors have
been shown to interact synergistically in the activation of the
T-cell receptor d and g enhancers (Hernandez-Munain andKrangel, 1994; Hsiang et al., 1995) and in the activation of a
murine leukemia retroviral enhancer (Zaiman and Lenz, 1996).
In the case of the former, the interaction does not involve coop-
erative DNA binding, suggesting that it may require inter-
mediary proteins (Hernandez-Munain and Krangel, 1995). In
vertebrate systems, both runt-domain and myb-domain tran-
scription factors are also known to interact with Ets-domain
transcription factors in the regulation of various genes (e.g.,
Reddy et al., 1994; Wotton et al., 1994; Zaiman and Lenz,
1996; Dudek et al., 1992). We note that a perfect target site for
an Ets-domain factor occurs 20 bp upstream of the myb target
site in the CyIIIa middle regulatory module (- 1252 to - 1257
in the sequence published by Thézé et al., 1990), and a close
match (5/6) for the Ets target site occurs immediately adjacent
to the SpRunt-1 target site. There is no evidence at present that
either of these sites bind Ets-domain proteins or function in
regulating CyIIIa transcription. However, an Ets factor is
expressed in sea urchin embryos, and its mRNA is prevalent in
early embryos (Chen et al., 1988).
The interaction between SpMyb and SpRunt-1, and perhaps
an Ets factor as well, are specified by the target sites encoded
in the cis-regulatory DNA of the CyIIIa middle module, which
can thus be thought of as a ‘hard-wired’ genomic regulatory
subsystem (Arnone and Davidson, 1997). The comparative
evidence indicates the remarkable conservation of the main
working component of this subsystem, a sequence element that
includes target sites for runt, myb, and Ets transcription factors.
Here this element functions as a spatial on-or-off switch, a role
that is likely to be useful in many different developmental
regulatory contexts, and in many different genes.
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